Lymphoid-Tissue Stromal Cells Coordinate Innate Defense to Cytomegalovirus

被引:20
|
作者
Verma, Shilpi [1 ]
Wang, Qiao [1 ]
Chodaczek, Grzegorz [2 ]
Benedict, Chris A. [1 ]
机构
[1] La Jolla Inst Allergy & Immunol, Div Immune Regulat, La Jolla, CA USA
[2] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA USA
关键词
NATURAL-KILLER-CELLS; IFN-ALPHA-BETA; MURINE CYTOMEGALOVIRUS; VIRAL-INFECTION; VIRUS-INFECTION; INTERFERON-ALPHA/BETA; IN-VIVO; MOUSE-CYTOMEGALOVIRUS; ACTIVATION RECEPTOR; DENDRITIC CELLS;
D O I
10.1128/JVI.00113-13
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
During mouse cytomegalovirus (MCMV) infection, the first wave of type I interferon (IFN-I) production peaks at similar to 8 h. This IFN-I emanates from splenic stromal cells located in the marginal zone (MZ) and requires B cells that express lymphotoxin. The amount of IFN-I produced at these initial times is at least equivalent in magnitude to that produced later by dendritic cells (similar to 36 to 48 h), but the relative roles of these two IFN-I sources in regulating MCMV defense remain unclear. Here we show that IFN-I produced by MZ stromal cells dramatically restricts the first measurable burst of viral production, which occurs at similar to 32 h. This primary innate control by IFN-I is partially mediated through the activation of natural killer (NK) cells, which produce gamma interferon in an IFN-I-dependent fashion, and is independent of Ly49H. Strikingly, MCMV production in the spleens of immunocompetent mice never increases at times after 32 h. These results highlight the critical importance of lymphoid-tissue stromal cells in orchestrating the earliest phase of innate defense to MCMV infection, capping replication levels, and blocking spread until infection is ultimately controlled.
引用
收藏
页码:6201 / 6210
页数:10
相关论文
共 50 条
  • [31] GLYCOSPHINGOLIPIDS OF WHITE CELLS LYMPHOID-TISSUE AND BONE-MARROW
    LEVIS, GM
    KESSEELI.M
    LIPIDS, 1974, 9 (09) : 651 - 657
  • [32] Secondary lymphoid-tissue chemokine induced modulation of T cells
    Vitiello, PF
    Rausch, MP
    Horowitz, KM
    Kurt, RA
    IMMUNOLOGICAL INVESTIGATIONS, 2004, 33 (02) : 235 - 249
  • [33] EXTRAMEDULLARY HAND MIRROR CELLS IN PATHOLOGICAL CONDITIONS OF LYMPHOID-TISSUE
    ZAHAROPOULOS, P
    WONG, JY
    WEN, JW
    ACTA CYTOLOGICA, 1990, 34 (06) : 868 - 874
  • [34] LYMPHOID-TISSUE OF THE NORMAL FALLOPIAN-TUBE - A FORM OF MUCOSAL-ASSOCIATED LYMPHOID-TISSUE (MALT)
    MORRIS, H
    EMMS, M
    VISSER, T
    TIMME, A
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1986, 5 (01) : 11 - 22
  • [35] Human Mesenchymal Stromal Cell Interactions with Innate Lymphoid Cells
    Christy, Barbara A.
    Cantu, Carolina
    Parida, Bijaya
    Herzig, Maryanne C.
    Bynum, James A.
    Cap, Andrew P.
    TRANSFUSION, 2018, 58 : 22A - 22A
  • [36] ORGANIZATION OF INVADING LYMPHOID-TISSUE IN HUMAN LYMPHOID THYROIDITIS
    SODERSTROM, N
    BIORKLUND, A
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1974, 3 (03) : 295 - 301
  • [37] LYMPHOID-TISSUE IN THE PROCESS OF PHYLOGENESIS AND ONTOGENESIS
    CHERNYSHENKO, LV
    CHERNOKULSKY, ST
    VRACHEBNOE DELO, 1989, (02): : 72 - 76
  • [38] PHOSPHOFRUCTOKINASE AND REGULATION OF GLYCOLYSIS IN LYMPHOID-TISSUE
    HICKMAN, PE
    WEIDEMAN.MJ
    PROCEEDINGS OF THE AUSTRALIAN BIOCHEMICAL SOCIETY, 1974, 7 (MAY27): : 40 - 40
  • [39] AN IMMUNOHISTOLOGICAL STUDY OF REACTIVE LYMPHOID-TISSUE
    MORRIS, HB
    MASON, DY
    STEIN, H
    LENNERT, K
    HISTOPATHOLOGY, 1983, 7 (06) : 809 - 823
  • [40] DENTAL DEVELOPMENT AND THE PHARYNGEAL LYMPHOID-TISSUE
    COCCARO, PJ
    COCCARO, PJ
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1987, 20 (02) : 241 - 257